banner

ODISHA BYTES

  • email
  • twitter
  • linkedin
  • facebook
Injected Benlysta Is Effective Alternative to IV for Treating Lupus, Phase 3 Trial Shows
An injected formulation of Benlysta (belimumab) is a safe and effective lupus treatment, according to a Phase 3 clinical trial that tested an...

Xencor's Candidate Antibody Therapy for Lupus Shows Positive Results in Phase 2 Study
Xencor announced top-line results from its Phase 2 clinical trial testing the candidate antibody therapy XmAb5871 for the treatment of systemic...

XTL Biopharmaceuticals To Focus On Core Asset SLE/Lupus And Multiple Myeloma Drugs
Raanana, Israel based XTL Biopharmaceuticals Ltd. (XTL) has announced that following evaluation of market opportunity for its pipeline products...

Neovacs' Investigational Lupus Vaccine Shows Positive Results in Phase 2B Trial
IFN-alpha Kinoid, an investigational vaccine by Neovacs, has a favorable safety profile and showed encouraging signs of effectiveness in...

Loading company panel...